跳到正文

Superstring Capital Management LP 13F 持仓 · 2026年Q2

Superstring Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 32 只证券,申报市值合计 1.58 亿美元。前几大持仓:COGT(8.39%)、AXSM(8.33%)、GMAB(7.47%)。本季前 25 大持仓中:新建仓 4 只、增持 12 只、减持 9 只。

排名代码公司市值占组合股数变动
1COGTCOGENT BIOSCIENCES INC$13.3M8.39%343,284增持
2AXSMAXSOME THERAPEUTICS INC.$13.2M8.33%53,916增持
3GMABGENMAB A/S$11.8M7.47%430,600增持
4CLDXCELLDEX THERAPEUTICS INC NEW$10.7M6.76%287,583增持
5TRVITREVI THERAPEUTICS INC$9.8M6.17%524,224增持
6RVMDREVOLUTION MEDICINES INC$9.6M6.04%51,053新建仓
7DFTXDEFINIUM THERAPEUTICS INC$8.9M5.59%188,282减持
8VIRVIR BIOTECHNOLOGY INC$8.7M5.49%853,685增持
9IMVTIMMUNOVANT INC$8.0M5.07%208,368减持
10URGNUROGEN PHARMA LTD$7.0M4.45%191,313减持
11CLYMCLIMB BIO INC$6.8M4.29%521,082增持
12ANLADLAI NORTYE LTD$6.4M4.01%552,501增持
13SVRASAVARA INC$6.0M3.80%977,460减持
14MPLTMAPLIGHT THERAPEUTICS INC$4.5M2.84%125,432减持
15ORICORIC PHARMACEUTICALS INC$4.4M2.78%406,077增持
16PCVXVAXCYTE INC$3.9M2.45%66,793减持
17UTHRUNITED THERAPEUTICS CORP DEL$3.9M2.45%7,172增持
18ONCBEONE MEDICINES LTD$3.5M2.21%12,273新建仓
19CABACABALETTA BIO INC$3.5M2.20%1.3M增持
20ZLABZAI LAB LTD$3.0M1.87%155,813减持
21SIONSIONNA THERAPEUTICS INC$2.8M1.75%63,156减持
22DRUGBRIGHT MINDS BIOSCIENCES INC$2.1M1.35%30,456增持
23ACRSACLARIS THERAPEUTICS INC$1.4M0.86%257,675减持
24HELPCYBIN INC$1.4M0.85%204,424新建仓
25KNSAKINIKSA PHARMACEUTICALS INTL$1.2M0.76%18,867新建仓

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR